Metrics as of 10/14/2026, 08:40 AM (Berlin time), refresh in progress.
OSR Holdings Stock
OSR Holdings, Inc.
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- CEO
- Kuk Hyoun Hwang
- Employees
- 22
- Market cap
- $4 M
- IPO
- 21/03/2023
OSR Holdings, Inc. operates as a Special Purpose Acquisition Company (SPAC) – essentially a blank check entity. Its primary objective is to execute a substantial business combination, which may take the form of a merger, a capital stock exchange, an asset acquisition, a stock purchase, a reorganization, or other…
OSR Holdings stock: price history
1D
+61.8%
1W
+10.0%
1M
-38.6%
6M
-32.9%
YTD
-51.2%
1Y
-64.6%
2Y
-97.5%
5Y
–
10Y
–
Next earnings date
Next earnings date
02/12/2026 (in 46 days)
Volatility around earnings
~6% weaker price swings than usual
Ask the agents about OSR Holdings
OSR Holdings stock metrics
P/E
-0.03
P/B
0.01
EV/EBITDA
-0.41
RETURN ON EQUITY
-1.0%
NET MARGIN
-318.1%
DEBT/EQUITY
0.01
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
44.2%
FLOAT SHARES
14,654,229
AVG. DAILY VOLUME (30D)
20,130,330
Institutional holders
Comparable stocks
Frequently asked questions about OSR Holdings stock
What does OSR Holdings do?
OSR Holdings, Inc. is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is Kuk Hyoun Hwang, the company employs around 22 people.
The IPO was on 21/03/2023; the stock trades on NASDAQ under the ticker OSRH.
When does OSR Holdings report next?
The next earnings date is 02/12/2026.
Around past earnings, price swings were roughly -6% stronger than usual.
Does OSR Holdings pay a dividend?
No, OSR Holdings currently does not pay a dividend.
Which stocks are comparable to OSR Holdings?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
How can I get OSR Holdings stock analyzed?
Clicking "Analyze stock" lets five strategies assess OSR Holdings against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.